Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial

Detalles Bibliográficos
Autores principales: Howaldt, Stefanie, Domènech, Eugeni, Martinez, Nicholas, Schmidt, Carsten, Bokemeyer, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889305/
https://www.ncbi.nlm.nih.gov/pubmed/34612489
http://dx.doi.org/10.1093/ibd/izab224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889305/
https://www.ncbi.nlm.nih.gov/pubmed/34612489
http://dx.doi.org/10.1093/ibd/izab224

Ejemplares similares